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We report a hybrid system, fabricated from nanostructured lipid particles and 1 
polysaccharide based hydrogel, for sustained release applications. Lipid particles were 2 
prepared by kinetically stabilizing self-assembled lipid nanostructures whereas the hydrogel 3 
was obtained by dissolving kappa-carrageenan (KC) in water. The drug was incorporated in 4 
native as well as lipid particles loaded hydrogels, which upon dehydration formed thin 5 
films. The kinetics of drug release from these films was monitored by UV-Vis spectroscopy 6 
while the films were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy 7 
and small angle x-ray scattering techniques. Pre-encapsulation of a drug into lipid particles 8 
is demonstrably advantageous in certain ways; for instance, direct interactions between KC 9 
and drug molecules are prohibited due to the mediation of hydrophobic forces generated by 10 
lipid tails. Rapid diffusion of small drug molecules from porous hydrogel network is 11 
interrupted by their encapsulation into rather large sized lipid particles. The drug release 12 
from the lipid-hydrogel matrix was sustained by an order of magnitude timescale with 13 
respect to the release from native hydrogel films. These studies form a strong platform for 14 
the development of combined carrier systems for controlled therapeutic applications.  15 
2 
 
1. Introduction 1 
Nanostructured lipid particles, also called ‘isasomes’(Yaghmur et al., 2005) (internally self-2 
assembled somes-particles) have demonstrably proved their potential as delivery vehicles for 3 
active molecules such as drugs, proteins and genes (Angelova et al., 2011; Han et al., 2010; 4 
Hirlekar et al., 2010; Yaghmur and Glatter, 2009). These particles are simply oil-in-water 5 
(O/W) type emulsions (Fig.1) but the fascination lies in their interior, which is comprised of 6 
highly organized self-assembled lipid nanostructure that can be cubic or hexagonal 7 
(Gustafsson et al., 1996, 1997); corresponding particles are called ‘cubosomes’ and 8 
‘hexosomes’. The internal nanostructure can be further varied to lamellar, sponge and 9 
reverse micellar phases (Kulkarni, 2012). Advantages of dispersed lipid particles with 10 
respect to their bulk (equilibrium phases) counterparts involve much lower viscosity, ability 11 
to withstand extremely high levels of dilutions, easier to manipulate and availability of much 12 
larger surface area (Kulkarni and Glatter, 2012). Apparent viscosity of a dispersion of lipid 13 
particles can be altered further by varying concentration of dispersed phase up to a certain 14 
extent (~70 % in some cases (Salentinig et al., 2008)) but a greater control can be achieved 15 
by forming thick, durable hydrogels in the aqueous region (continuous phase) (Guillot et al., 16 
2009; Tomsic et al., 2009). Hydrogels can be formed from natural polymers such as 17 
cellulose, starch, carrageenan and chitosan which are often used in food and cosmetic 18 
industries as thickeners or viscosity enhancers (Kadajji and Betageri, 2011; Shit and Shah, 19 
2014). In addition to their non-toxicity, biocompatibility and biodegradability, these 20 
polymers exhibit good swelling properties thanks to their three-dimensional cross-linked 21 
hydrophilic networks that are capable of holding large volumes of water (typically in the 22 
range of 30 to 90 %) (Shit and Shah, 2014). The highly porous structure of these hydrogel 23 
networks facilitates the encapsulation of various bioactive molecules such as drugs, proteins 24 
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and DNA. Therefore they are being widely explored for controlled delivery applications 1 
(Kadajji and Betageri, 2011; Lee et al., 2013).  2 
 Reversible incorporation of nanostructured lipid particles in hydrogels was first 3 
demonstrated by Tomsic et al. (Tomsic et al., 2009) and Guillot et al. (Guillot et al., 2009). 4 
The concept was further extended towards formation of dry films (Kulkarni et al., 2011). 5 
Nanostructured lipid particles could be retrieved back upon rehydration and re-dissolution of 6 
gel films. Important properties of lipid particles-the size and the nanostructure were 7 
preserved consequent to the above hysteresis (Kulkarni et al., 2011). We have employed this 8 
approach to develop a hybrid system for drug delivery. The hybrid system was formulated 9 
by loading the drug in the dispersion of nanostructured lipid particles and mixing it with the 10 
hydrogel; the mixture was then poured in custom made moulds and dehydrated to form drug 11 




Fig.1 a) Structural unit of KC forming cross-linked hydrogel network which looks stiff and transparent in 1 
upside down glass vial. b) Amphiphilic lipid molecule forms lipid cubic phase inside the particles stabilized by 2 
pluronic F127 stabilizer upon ultrasonication. These particles are then loaded with drug and mixed with KC 3 
hydrogel in equal ratio to form opaque hydrogel as shown in c). Schematic diagrams are used for ease of 4 
understanding the constituents and their location.  5 
The hydrogel used to formulate hybrid system was prepared from kappa (κ)-carrageenan 6 
(KC). It is a high molecular weight anionic sulphated linear polysaccharide of D-galactose 7 
and 3,6-anhydro D-galactose (Fig. 1a) originated from red seaweed of the Rhodophyceae 8 
family (Prajapati et al., 2014). The KC hydrogel forms at room temperature (sol-gel 9 
transition at 28.4 °C in cooling direction (Tomsic et al., 2008)) and melts above 60 °C. 10 
Although the gel formed from mere 2 % KC is rather stiff (storage modulus G’ ~104 Pa, 11 
Note: storage modulus is a property of viscoelastic materials and can be used to estimate gel 12 
strength) (Tomsic et al., 2008), it is a ‘physical gel’ which imbibes large amount of water 13 
and constitutes irregular pores ranging up to 600 µm size (Daniel-da-Silva et al., 2007). 14 
Because of these characteristics, KC pellets employed for drug delivery applications were 15 
found to disintegrate faster in aqueous media resulting in rapid release of drugs (Kranz et al., 16 
2009). Kranz et al. showed that about half of the drug gets released from KC pellets in first 17 
10 minutes while the release is almost complete within an hour. Other disadvantages of pure 18 
KC system are that they require expensive drying methods and they also suffer from stability 19 
problems for sensitive drugs (Bornhöft et al., 2005). However, modified forms of KC, its 20 
amalgamation with other polymers and encapsulation of micro/nanoparticles have shown to 21 
be more effective ways to use them as drug carriers (Li et al., 2014). In this report we have 22 
encapsulated drug loaded internally-self assembled soft lipid particles within a KC hydrogel 23 
to form dried films (Fig. 1b). These dehydrated films not only protect the drug in its native 24 
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form but also release it in an efficient and sustained manner. Systematic characterization of 1 
this and relevant control systems along with time-resolved studies of drug release process 2 
form central part of this work.  3 
2. Materials and Methods 4 
2.1 Materials 5 
Commercial grade Dimodan-U/J (DU) was a gift from Danisco, Denmark.  It is a distilled 6 
glyceride comprising 96 % monoglycerides (Fig. 1b) and the rest are diglycerides and free 7 
fatty acids. Two major monoglyceride components in DU are linoleate (62 %) and oleate (25 8 
%). Hence the hydrophobic part of DU mainly contains C18 chains (91%). The triblock 9 
copolymer Pluronic© F127 (PEO99 -PPO67-PEO99) (Fig. 1b) was purchased from Sigma-10 
Aldrich, UK. It was used as an emulsion stabilizer. The hydrogelling agent, KC (Fig. 1a) 11 
was obtained from Fluka Biochemika, Switzerland. Aspirin was purchased from Sigma-12 
Aldrich, UK. It is a salicylate drug (Fig. 1b) used mainly as analgesic and antipyretic agent. 13 
All the chemicals were used as received without any further purification. DU was stored 14 
below 4 °C whereas the other materials were kept at room temperature. Water used during 15 
entire study was purified using Barnstead Nanopure, Thermoscientific (USA). 16 
2.2 Preparation and Loading of Nanostructured Lipid Particles Nanostructured lipid particles 17 
were prepared according to the published method using slightly different compositions and 18 
parameters (Yaghmur et al., 2005). 500 mg of molten lipid (DU) was added to the 20 ml 19 
glass vial and topped with the stabilizer solution (prepared separately by dissolving 0.5 % 20 
pluronic F127 in 100 ml water) to give a total weight of 10 gm. The mixture was 21 
ultrasonicated (ULT065 from Ultrawave, Cardiff, UK) for 10 minutes with a continuous 22 
pulse at 35 % power. Samples became hot due to ultrasonication, hence were allowed to 23 
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cool to room temperature before further use. Drug was loaded by stirring 5 mg of aspirin (in 1 
powder form) into the above solution for about 15 min to ensure the drug was dissolved into 2 
the “milky” emulsion (of nanostructured lipid particles).  3 
2.3 Loading KC hydrogel   4 
4 % KC solution was prepared by stirring KC powder in 9.6 ml water on hot plate at 60 °C 5 
for around 20 minutes. The molten, pourable solution was combined with an equal amount 6 
of drug loaded nanostructured lipid particle dispersion and gently stirred (for 15-20 minutes) 7 
while heating until visual homogenization (Kulkarni et al., 2011). Native KC gel (without 8 
nanostructured lipid particles) was prepared by simply stirring 5 mg aspirin with 2 % KC 9 
solution at 60 °C.  10 
2.4 UV-Vis Spectroscopy 11 
UV-Visible spectroscopy (UV-3600, Shimadzu, UV-Vis NIR Spectrophotometer, Japan) 12 
was used to monitor drug release from drug loaded films in pure water. Using 4 ml quartz 13 
cuvettes the spectra in the range of wavelength 200-700 nm were recorded at every 30 or 60 14 
min. Typical release experiments were performed for about 24 hrs and a few long runs for 15 
42 hrs. All experiments were repeated at least three times.  16 
2.5 Small Angle X-ray Scattering 17 
Small angle x-ray scattering measurements (1.2-10 degrees) on dehydrated samples and dry 18 
films were performed using D2 Phaser (Bruker Instruments, UK). Typical settings of 0.1 19 
mm slit and 0.1 mm knife edge distance were used to acquire 1-dimensionsal data 20 
(integrated using DIFFRAC.SUITE over intensity) with LYNXEYETM detector. 21 
Measurements were performed at room temperature (20 °C). Typical measurements of 20 22 
minutes were sufficient to produce useful data.  23 
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2.6 Fourier Transform Infra-Red Spectroscopy 1 
A Thermoscientific Nicolet IR 200, FT-IR model was used to carry out the ATR-IR 2 
experiments. Spectra were generated for each type of film used as well as for each of their 3 
constituent components in the range of frequencies 400–4000 cm-1. All measurements were 4 
conducted at room temperature.  5 
 6 
Fig.2 a) Perspex 2-part mould designed in-house to produce 6 films at a time. Inset shows the dry 7 
film loaded with nanostructured lipid particles and a drug, which was placed at the bottom of 8 
cuvette as shown in b). The drug release in pure water as a function of time was recorded by UV-9 
spectroscopy at regular intervals. 10 
3. Results and discussion 11 
3.1 Preparation of Hydrogel Films for Drug Delivery 12 
Molten hydrogels (see section 2.3 for more details) were poured into custom designed (in-13 
house) moulds (Fig. 2a) to fabricate films. Six square holes of 6.0x6.0x1.2 mm dimensions 14 
were drilled by laser-cutting in a 1.2 mm thick Perspex sheet which was screwed to another 15 
similar sheet (Fig 2a) to construct well-like architectures. Above well dimensions were 16 
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chosen to produce films that can fully swell in aqueous media without virtually touching to 1 
the cuvette walls. Hydrogel films were formed after 42-48 hrs of drying in air (lost 98±1% 2 
water from gel), whereas semi-dried films were prepared by drying the gels in humid 3 
atmosphere for 24-30 hrs (lost 85±2% water from gel). The two part mould attachment 4 
served for easy removal of dried films. Using a flat-faced spatula, individual films were 5 
carefully immersed in pure water (at the bottom of 4 ml quartz cuvette). UV-Vis 6 
measurements were started immediately (Fig. 2b) and spectra were collected at regular 7 
intervals at room temperature. 8 
 9 
Fig. 3 a) Film thickness was increased linearly until loading of 7.5 % nanostructured lipid particles which seem to 10 
stabilize at 10 % concentration. This means more drug can be loaded in these films owing to the availability of more 11 
lipid particles without extreme change in the film dimensions. b) Small angle x-ray scattering patterns displaying typical 12 
upturn at low angles for hydrogel network. Nanostructure of lipid particles was converted from original cubic (Guillot 13 
et al., 2006) to hexagonal (characteristic indexing as 1,  √3,  √4) due to addition of a drug.   14 
3.2 Structure and Properties of Hydrogel Films 15 
Dry films of native KC were very thin (average thickness of ~0.4 mm), transparent and 16 
brittle while films loaded with nanostructured lipid particles were less transparent and thick; 17 
the thickness increased linearly with the amount of loading until 7.5 wt% dispersed phase 18 
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(Fig. 3a). The transparency is partly lost due to scattering from large lipid particles. The 1 
average particle size of nanostructured lipid particles was found in the range of 2-5 µm 2 
(measured by dynamic light scattering, see SI Fig. SI1). Films loaded with lipid particles 3 
were rather elastic compared to native KC films, which could be attributed to the 4 
viscoelastic and sticky nature of the lipid constituent.    5 
 A pink tinge was seen for native KC films upon drug loading while films loaded with 6 
nanostructured lipid particles did not show detectable pink tinge. Nevertheless, the drug 7 
loading into lipid particles could be confirmed by the transformation of an internal self-8 
assembly of lipid particles. The original bicontinuous cubic Pn3m nanostructure (Guillot et 9 
al., 2006) observed for pure lipid molecules (in water) was modulated to the hexagonal 10 
nanostructure due to incorporation of a drug as verified by small angle x-ray scattering (Fig. 11 
3b). This aspect turns out to be beneficial because the hexagonal phase is essentially 12 
constituted of water filled cylinders holding the drug for long lengths of time whereas for the 13 
bicontinuous cubic phase, because of its open channel network, it is presumed to release the 14 
drug at much higher rates (Phan et al., 2011). The influence of nanostructure-type on the 15 
release rates has been demonstrated by a few researchers working on similar lipid systems 16 
(Chemelli et al., 2012; Fong et al., 2009; Phan et al., 2011). Typical upturns at low angles 17 
(without other distinguishable peaks) observed for KC films (Fig. 3b) could be ascribed to 18 
large hydrogel networks (Tomsic et al., 2008).  19 
3.3 Drug Protection by Nanostructured Lipid Particles 20 
The Fourier Transform Infra-Red (FTIR) spectrum for drug-aspirin (red curve in Fig. 4) 21 
shows anticipated signals including a sharp peak at 1604 cm-1 (C=C aromatic stretch), a 22 
signal at 1677 cm-1 (conjugated acid C=O stretch), a peak at 1747 cm-1 (ester C=O stretch) 23 
and a broad peak around ~2800 cm-1 (acid O-H stretch). Several peaks for KC, as supported 24 
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by literature studies (Pereira et al., 2009), could also be identified from signals at 841 cm-1 1 
(corresponding to D-galactose-4-sulfate), 918 cm-1 (corresponding to 3,6-anhydro-D-2 
galactose), 1219 cm-1 (sulphate ester), and a broad peak at 3336 cm-1 (alcohol stretch).  3 
  4 
 5 
Fig. 4 FTIR spectra demonstrate that drug (aspirin) signals were retained after its loading into KC film together 6 
with nanostructured lipid particles while there was no measureable evidence of drug loading in the native KC 7 
films. Signals for lipid are shown by ♦ sign (see SI Fig. SI2 for lipid only spectrum) and aspirin peaks retained 8 
after loading are indicated by * sign in a drug spectra. 9 
An examination of the drug loaded KC film spectrum (Fig. 4) reveals that it is practically 10 
indistinguishable from the native KC film spectrum. Furthermore, no signals from aspirin 11 
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are obviously identifiable within the drug loaded KC film spectrum. Several reasons could 1 
be postulated to reveal the underlying mechanism of masking of drug signals by KC signals; 2 
for instance, a) the concentration of a drug loaded in 10 gm of hydrogel solution (used to 3 
prepare films) was mere 5 mg whereas the concentration of kappa-carrageenan (KC) was as 4 
high as 200 mg, b) some of the chemical groups/bonds are commonly found in both - drug 5 
and KC chemical structures and c) there are strong chances of hydrogen bonding and 6 
electrostatic interactions between these molecules which further mask the IR band resolution 7 
However, the acquisition of a slight pinkish hue and detectable UV-Vis signals during 8 
release studies imply that drug was successfully entrapped in the KC film. 9 
 Physico-chemical interactions between drug and KC network were also apparent from the 10 
UV-Vis studies. The reference UV-Vis spectrum of aspirin showed distinct peaks at 225 nm 11 
and 275 nm (SI Fig. SI3) whereas these peaks were shifted to higher wavelengths in case of 12 
released aspirin from native and lipid particles-loaded hydrogel films (see SI Fig. SI3). The 13 
peak-shifts could be attributed to the chromophoric interactions between functional groups 14 
of the components. However, these aspects were not studied in much depth here as the focus 15 
of the current report is towards introducing a hybrid drug carrier system and establishing a 16 
method to produce prototype for drug delivery applications.  17 
 In case of drug+lipid particles loaded KC films, a small acid/ester stretch at 1727 cm-1, an 18 
alkyl C-H stretches at 2854 cm-1 and 2915 cm-1 and a broad alcohol stretch at 3363 cm-1 19 
represent lipid signals (spectra of lipid only and drug loaded lipid particles are provided in SI 20 
Fig. SI2 for reference). In addition, some discernible aspirin signals were also observed 21 
(indicated by * sign in Fig. 4). Here, the drug was preloaded into lipid particles followed by 22 
their incorporation into the hydrogel matrix. The repulsion between hydrophobic lipid tails 23 
(of inverse lipid nanostructures) and KC strands is presumed to avoid the masking of aspirin 24 
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signals by KC signals. It simply means that the lipid molecules act as a barrier for 1 
electrostatic and hydrogen bonding interactions between aspirin and KC structures thereby 2 
effectively protecting the structural form of a drug as opposing to the native KC films. This 3 
drug pre-encapsulation, in fact, was advantageous for sustaining the release as discussed 4 
below.  5 
 6 
Fig.5 Drug release from native hydrogel films (x, + and ο) stabilized in early hours whereas lipid particles loaded films 7 
(●, ■ and▲) sustained drug for a longer length of time. Large changes in absorbance values in case of films with lipid 8 
particles as compared to native films (qualitatively) represent release of more drug from lipid particles loaded films. 9 
Individual curves represent a different set of experiments performed under same conditions. Noisy curves after initial 10 
peak (after 700-800 min) could be due to possible disintegration of films to release nanostructured lipid particles 11 
passing randomly across the beam. 12 
3.4 Drug Release from Semi-dried Films 13 
Films dried for 24-30 hrs in humid atmosphere were rather soft and more hydrated than 14 
those prepared in dry atmosphere (for 42-48 hrs). Drug release from these semi-dried films 15 
was monitored by time-resolved collection of UV-spectra similar to Fig 2b. A fixed value of 16 
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wavelength was determined by Gaussian fit to the broad peak around 255-320 nm. 1 
Absorbance values at this wavelength (294 nm) were plotted against experimental time as 2 
shown in Fig. 5. Three curves (indicated by x, + and ο) demonstrate that the drug release 3 
from native KC films was gradual in first 3-4 hrs and it stabilized soon after that. Release 4 
from lipid loaded films was practically similar in early hours but it was clearly faster after 5 
about 10-12 hrs (shown by ●, ■ and▲). This can be attributed to the dissolution of hydrogel 6 
network followed by the disintegration of the whole film. Latter leads to a discharge of 7 
entrapped lipid particles, which presumably pass across the UV-Vis beam randomly as 8 
reflected in the noisy data after a peak around 700-800 min. Visible changes occurring with 9 




Fig. 6 a) Drug release studied for 48 hrs from fully dried native and lipid particles loaded hydrogel films. Shaded 2 
regions (A, B, and C) indicate the possible mechanism of drug release from hydrogel films while the noisy data due to 3 
discharge of lipid particles is shown in D. The release from native film only occurs during early hours, which stabilizes 4 
in about 600 mins (shown by ●). Moreover, the amount of drug released is far too less (low absorbance values) as 5 
compared to the total release from lipid loaded films (shown with ♦) as depicted by I and II. b) Relative swelling of a 6 
drug+lipid particle loaded film (thickness of the film normalized by cuvette-bottom length) practically matches with 7 
15 
 
suggested mechanism in a). c) Images captured at various time intervals apparently reflect possible physical processes 1 
associated with hydrogel films during drug release studies. Yellow arrows indicate shape changes due to dissolution of 2 
hydrogel network.        3 
3.5 Understanding the Processes Responsible for Drug Release 4 
Although the drug release curves obtained for semi-dried and fully dried films virtually 5 
followed same patterns, their absolute times differed by a few hrs (Figs. 5 and 6). Semi-dried 6 
films disintegrated about 900 min faster than fully dried ones, which was also the case for 7 
rapid drug release prior to this step.  8 
 Different drug release rates and release times could underlay different physical processes 9 
as described below. Initial rapid release (within first 10 hrs) could be due to swelling of a 10 
film (Fig 6). During this time the dehydrated hydrogel network absorbs a maximum amount 11 
of water, thereby untightening of the hydrogel network takes place. This facilitates the 12 
release of entrapped drug from the hydrogel network (Region A in Fig. 6a). The swollen 13 
network starts dissolving in water causing gradual drug release in the next 15 hrs (Region B 14 
in Fig. 6a). This slow-down could be due to hindrance caused by lipid particles. A rapid 15 
release of film content after ~24 hrs could be attributed to the release from lipid particles 16 
(Region C in Fig. 6a) as their pores (aqueous channels of internally self-assembled 17 
nanostructure) open up due to the complete dissolution of the hydrogel network surrounding 18 
them. This can be validated from the fact that the rate of drug release (slope of 0.0014) from 19 
mere lipid particles (investigated independently see SI Fig. SI4) and the release in the 20 
Region C (slope of 0.0018) were quite comparable. The amount of drug released from lipid 21 
loaded films was about an order of magnitude higher than the drug released from native 22 
films (arbitrated from change in the initial absorbance values) as indicated by I and II in Fig. 23 
6.  These attributes along with FTIR results (section 2.3) convincingly prove that the 24 
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efficiency of drug release from hybrid system was higher than in pure system, presumably 1 
because some of the drug seized by KC and drug interactions (in native films) was free to be 2 
released from the hybrid system due to lipid intervention. In late stages of dissolution, the 3 
hydrogel network plausibly becomes sparse enough to discharge the entrapped lipid particles 4 
leading to the noisy data after 2050 min (Region D in Fig 6). However, noticeable 5 
disintegration of the film was only captured on camera at 2520 min (Fig 6c).   6 
4. Conclusions 7 
We have presented a novel application of lipid particles-loaded hydrogel films in the field of 8 
drug delivery. As the main aim of the current work was to demonstrate the applicability of 9 
the lipid-hydrogel films, we did not emphasize on the structural form and activity of the drug 10 
in this system. However, it is clear that the encapsulation of drug molecules in lipid particles 11 
is advantageous, in many ways. For instance, the drug release timescale was prolonged by 12 
almost an order of magnitude as compared to the release from KC films; in addition, it was 13 
released in more efficient manner (more drug was released). Furthermore, lipid particles 14 
practically improve the stability of the drug which appears to have lost due to possible 15 
bonding with KC network in native films. We were able to recognize the physical processes 16 
responsible for differential release rates of drugs at various timescales. The lipid-hydrogel 17 
composite system, presented here, finds an enormous potential for development of 18 
therapeutic carriers in a range of pharmaceutical and cosmetic applications.       19 
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